Senti Biosciences Holdings, Inc.
SNTI
$0.96
-$0.01-0.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -0.15% | 21.50% | 9.59% | 5.72% | -14.80% |
| Gross Profit | 0.44% | -21.50% | -9.59% | -5.72% | 14.80% |
| SG&A Expenses | -78.26% | 28.05% | 97.98% | -10.86% | -75.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.80% | 24.25% | 29.25% | -2.25% | -42.85% |
| Operating Income | 16.02% | -24.25% | -29.25% | 2.25% | 42.85% |
| Income Before Tax | -2,271.64% | 37.21% | -31.51% | -16.52% | 96.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2,271.64% | 37.21% | -31.51% | -16.52% | 96.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2,271.64% | 37.21% | -31.51% | -16.52% | 96.74% |
| EBIT | 16.02% | -24.25% | -29.25% | 2.25% | 42.85% |
| EBITDA | 17.23% | -26.19% | -32.41% | 1.99% | 45.16% |
| EPS Basic | 21.36% | 89.04% | 76.95% | 46.81% | 83.97% |
| Normalized Basic EPS | -154.32% | 71.55% | 77.28% | 46.93% | 96.78% |
| EPS Diluted | 21.36% | 89.04% | 76.95% | 46.81% | 83.97% |
| Normalized Diluted EPS | -154.32% | 71.55% | 77.28% | 46.93% | 96.78% |
| Average Basic Shares Outstanding | 487.42% | 473.03% | 470.46% | 119.07% | 4.37% |
| Average Diluted Shares Outstanding | 487.42% | 473.03% | 470.46% | 119.07% | 4.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |